Market by Test Type, Treatment, and Regional Outlook | Forecast 2023-2030
Male infertility is a health condition arising from
defective sperm function, obstructions, or low sperm production, preventing
sperm delivery. Moreover, it is influenced by ailments, long-term health
problems, accidents, lifestyle changes, etc. In
this regard, assisted reproductive technologies offer a quick resolution,
witnessing a high adoption rate compared to conventional treatment methods.
According to Triton
Market Research’s report, the Global Male Infertility Market garnered $3982.19 million
in 2022 and is expected to reach $5780.03
million by 2030, growing at a CAGR
of 4.81% during the forecast period 2023-2030.
Click here to check out our blog on the Global Male Infertility Market
MARKET PERFORMANCE: DRIVERS, CHALLENGES, AND OPPORTUNITIES
Over the forecast period, the surging
incidence of infertility, adoption of assisted reproductive technologies, and
technological advancements are expected to fuel the studied
market’s growth. Over the past few decades, infertility
research has advanced significantly. New emerging technologies are being
developed and researched, such as microfluidic sperm function assays, to detect
sperm with the least amount of DNA damage. Also, there are strong prospects for
the use of artificial intelligence in sperm selection. These technologies hold
the potential to develop efficient diagnostic and therapeutic alternatives.
However, the market must
overcome significant obstacles like the
high cost of the treatment. As per the Biology of
Reproduction research paper, ART is expensive and typically not covered by most
health insurance. The failure of nearly 75% of IVF/ICSI cycles forces couples
to undergo further rounds of therapy, which raises the overall cost of care. According
to industry sources, as of 2023, IVF cycles would likely cost between $12,000
and $14,000 at infertility clinics in the United States. A single IVF round
could cost $30,000 or more, depending on the needs. The cost of IVF at a
facility often includes monitoring consultations, blood tests, follow-up
visits, and egg retrieval. Most clinics do not include the cost of injectable
hormones in their quoted prices, often paid directly to the pharmacy supplying
the prescription. Hence, this is expected to restrict the global male
infertility market growth during the forecast period.
Nevertheless, government
initiatives to improve reimbursement scenarios for infertility-related
treatments are expected to create opportunities for the studied market.
For instance, the New York State Department of Health (NYSDOH) provides grant
assistance to higher volume providers of infertility services under the New
York State Infertility Reimbursement Program. Also, the government of India
offers reimbursements for infertility treatments. This amount includes
disposables, drugs, and monitoring costs during procedures.
Report scope can be customized per your requirements - Request Free Sample Report
KEY GEOGRAPHIES COVERED:
• North America: United States and Canada
• Europe: United
Kingdom, Germany, France, Italy, Spain, Poland, and Rest of Europe
• Asia-Pacific: China,
Japan, India, South Korea, ASEAN Countries, Australia & New Zealand, and
Rest of Asia-Pacific
• Latin America: Brazil,
Mexico, and Rest of Latin America
• Middle East and Africa: Saudi
Arabia, Turkey, United Arab Emirates, South Africa, and Rest of Middle East
& Africa
SEGMENTATION ANALYSIS – MALE INFERTILITY MARKET:
• Market by Test Type:
o DNA
Fragmentation Technique
o Oxidative
Stress Analysis
o Microscopic
Examination
o Sperm
Agglutination
o Computer-Assisted
Semen Analysis
o Sperm
Penetration Assay
o Other Test
Types
Sperm agglutination is
expected to be the fastest-growing test type in the market during the forecast
period. Sperm agglutination measures the percentage
of sperm. In order to diagnose male infertility, a semen analysis is regarded
as the gold standard diagnostic technique, according to the National Institute
of Health. Ascorbic acid insufficiency and genital tract infections are two
causes of sperm agglutinations.
• Market by Treatment:
o Assisted
Reproductive Technology and Surgery
o Medications
Assisted reproductive
technology and surgery dominate the market in terms of treatment.
It includes medical procedures, such as IntraCytoplasmic Sperm Injection
(ICSI), in vitro fertilization (IVF), cryopreservation, Preimplantation Genetic
Diagnosis (PGD), frozen oocyte replacement, and Intrauterine Insemination (IUI)
included in ART to treat male factor infertility. There have been significant
developments in the ART industry by the market players, which is likely to support
the segment’s growth.
COMPETITIVE LANDSCAPE
The male infertility
market by company profile helps dive into data about the key players in this
industry. The strategic initiatives for each of the companies considered have
been covered in detail.
Expansion
(2023): Progyny Inc
Progyny Inc (a benefits management company
pioneering in fertility and family-building benefits solutions) expanded its
provider network to include reproductive urologists.
Collaboration
(2023): Posterity Health and Frame Fertility
Posterity
Health joined forces with Frame Fertility to
offer new methods to approach fertility challenges while encouraging male
assessment early in the family-building process. This step focuses on ensuring
equal access for males to fertility resources.
KEY BENEFITS OF THE REPORT:
· Triton Market Research has a collective experience of 25-30 years in the industry, with its analysts and experts encompassing the most infallible research methodology for its market intelligence and industry analysis.
· Our research methodology helps in achieving a broader consensus of the market size, shape, and industry trends within each industry segment.
· The strategy adopted in designing the research methodology includes the amalgamation of the information assembled from primary and secondary sources, with the assistance of analytical tools to construct the forecast and predictive models.
·
The
scope of the market report comprises the current scenario of the global male
infertility market, along with a detailed overview of the industry outlook,
market dynamics, segmentation analysis, regional outlook, and competitive
landscape for the period 2023-2030.
FAQs:
Q 1)
Advancements in diagnostic techniques, rising demand for assisted reproductive technologies (ART), focus on male reproductive health, and adoption of lifestyle and dietary modifications are some of the latest trends supporting the market growth over the forecast period 2023-2030.
Q 2) Which test type dominates the male infertility market?
DNA fragmentation
technique accounted for the largest market share in revenue in 2022 and is
expected to dominate the market during the forecast period.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL
MALE INFERTILITY MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. PARENT
MARKET ANALYSIS
2.2. IMPACT
ANALYSIS ON THE MALE INFERTILITY MARKET
2.2.1. COVID-19
IMPACT
2.2.2. UKRAINE-RUSSIA
WAR IMPACT
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
MATURITY ANALYSIS
2.5. KEY
MARKET STRATEGIES
2.5.1. COLLABORATIONS
2.5.2. PRODUCT
LAUNCHES
2.5.3. MERGERS
& ACQUISITIONS
2.5.4. BUSINESS
DIVESTITURES & EXPANSIONS
2.6. MARKET
DRIVERS
2.6.1. PREVALENCE
OF INFERTILITY
2.6.2. USE OF
ASSISTED REPRODUCTIVE TECHNOLOGIES
2.6.3. TECHNOLOGICAL
INNOVATIONS AND ADVANCEMENTS
2.7. MARKET
CHALLENGE
2.7.1. HIGH COST
OF TREATMENT
2.8. MARKET
OPPORTUNITIES
2.8.1. INCREASING
ACCEPTANCE OF MINIMALLY INVASIVE SURGERIES
2.8.2. GROWING
AVAILABILITY OF INFERTILITY TREATMENT DRUGS, PROCEDURES, AND DEVICES
2.8.3. GOVERNMENT
INITIATIVES TOWARD IMPROVING REIMBURSEMENT POLICIES
2.9. ANALYST
PERSPECTIVE
3. GLOBAL
MALE INFERTILITY MARKET – BY TEST TYPE
3.1. DNA
FRAGMENTATION TECHNIQUE
3.2. OXIDATIVE
STRESS ANALYSIS
3.3. MICROSCOPIC
EXAMINATION
3.4. SPERM
AGGLUTINATION
3.5. COMPUTER-ASSISTED
SEMEN ANALYSIS
3.6. SPERM
PENETRATION ASSAY
3.7. OTHER
TEST TYPES
4. GLOBAL
MALE INFERTILITY MARKET – BY TREATMENT
4.1. ASSISTED
REPRODUCTIVE TECHNOLOGY AND SURGERY
4.2. MEDICATIONS
5. GLOBAL
MALE INFERTILITY MARKET – BY REGIONAL OUTLOOK
5.1. NORTH
AMERICA
5.1.1. MARKET
BY TEST TYPE
5.1.2. MARKET
BY TREATMENT
5.1.3. COUNTRY
ANALYSIS
5.1.3.1. UNITED
STATES
5.1.3.1.1. UNITED
STATES MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.1.3.2. CANADA
5.1.3.2.1. CANADA
MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.2. EUROPE
5.2.1. MARKET
BY TEST TYPE
5.2.2. MARKET
BY TREATMENT
5.2.3. COUNTRY
ANALYSIS
5.2.3.1. UNITED
KINGDOM
5.2.3.1.1. UNITED
KINGDOM MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.2.3.2. GERMANY
5.2.3.2.1. GERMANY
MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.2.3.3. FRANCE
5.2.3.3.1. FRANCE
MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.2.3.4. ITALY
5.2.3.4.1. ITALY
MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.2.3.5. SPAIN
5.2.3.5.1. SPAIN
MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.2.3.6. POLAND
5.2.3.6.1. POLAND
MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.2.3.7. REST
OF EUROPE
5.2.3.7.1. REST OF
EUROPE MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.3. ASIA-PACIFIC
5.3.1. MARKET
BY TEST TYPE
5.3.2. MARKET
BY TREATMENT
5.3.3. COUNTRY
ANALYSIS
5.3.3.1. CHINA
5.3.3.1.1. CHINA
MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.3.3.2. JAPAN
5.3.3.2.1. JAPAN
MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.3.3.3. INDIA
5.3.3.3.1. INDIA
MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.3.3.4. SOUTH
KOREA
5.3.3.4.1. SOUTH
KOREA MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.3.3.5. ASEAN
COUNTRIES
5.3.3.5.1. ASEAN
COUNTRIES MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.3.3.6. AUSTRALIA
& NEW ZEALAND
5.3.3.6.1. AUSTRALIA
& NEW ZEALAND MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.3.3.7. REST
OF ASIA-PACIFIC
5.3.3.7.1. REST
OF ASIA-PACIFIC MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.4. LATIN
AMERICA
5.4.1. MARKET
BY TEST TYPE
5.4.2. MARKET
BY TREATMENT
5.4.3. COUNTRY
ANALYSIS
5.4.3.1. BRAZIL
5.4.3.1.1. BRAZIL
MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.4.3.2. MEXICO
5.4.3.2.1. MEXICO
MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.4.3.3. REST
OF LATIN AMERICA
5.4.3.3.1. REST
OF LATIN AMERICA MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.5. MIDDLE
EAST AND AFRICA
5.5.1. MARKET
BY TEST TYPE
5.5.2. MARKET
BY TREATMENT
5.5.3. COUNTRY
ANALYSIS
5.5.3.1. UNITED
ARAB EMIRATES
5.5.3.1.1. UNITED
ARAB EMIRATES MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.5.3.2. TURKEY
5.5.3.2.1. TURKEY
MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.5.3.3. SAUDI
ARABIA
5.5.3.3.1. SAUDI
ARABIA MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.5.3.4. SOUTH
AFRICA
5.5.3.4.1. SOUTH
AFRICA MALE INFERTILITY MARKET FORECAST & PROSPECTS
5.5.3.5. REST
OF MIDDLE EAST AND AFRICA
5.5.3.5.1. REST
OF MIDDLE EAST & AFRICA MALE INFERTILITY MARKET FORECAST & PROSPECTS
6. COMPETITIVE
LANDSCAPE
6.1. HALOTECH
DNA
6.1.1. OVERVIEW
6.1.2. PRODUCT
PORTFOLIO
6.2. EMD
SERONO INC
6.2.1. OVERVIEW
6.2.2. PRODUCT
PORTFOLIO
6.2.3. KEY
STRENGTHS
6.2.4. KEY
CHALLENGES
6.3. ENDO
INTERNATIONAL PLC
6.3.1. OVERVIEW
6.3.2. PRODUCT
PORTFOLIO
6.3.3. KEY
STRENGTHS
6.3.4. KEY
CHALLENGES
6.4. VITROLIFE
6.4.1. OVERVIEW
6.4.2. PRODUCT
PORTFOLIO
6.4.3. KEY
STRENGTHS
6.4.4. KEY
CHALLENGES
6.5. BAYER AG
6.5.1. OVERVIEW
6.5.2. PRODUCT
PORTFOLIO
6.5.3. KEY
STRENGTHS
6.5.4. KEY
CHALLENGES
6.6. AYTU
BIOPHARMA
6.6.1. OVERVIEW
6.6.2. PRODUCT
PORTFOLIO
6.6.3. KEY
STRENGTHS
6.6.4. KEY
CHALLENGES
6.7. ZYDUS
LIFESCIENCES LIMITED
6.7.1. OVERVIEW
6.7.2. PRODUCT
PORTFOLIO
6.7.3. KEY
STRENGTHS
6.7.4. KEY
CHALLENGES
6.8. CINNAGEN
CO
6.8.1. OVERVIEW
6.8.2. PRODUCT
PORTFOLIO
6.8.3. KEY
STRENGTHS
6.8.4. KEY
CHALLENGES
6.9. SANOFI
SA
6.9.1. OVERVIEW
6.9.2. PRODUCT
PORTFOLIO
6.9.3. KEY
STRENGTHS
6.9.4. KEY
CHALLENGES
6.10. LABORATORY
CORPORATION OF AMERICA HOLDINGS
6.10.1. OVERVIEW
6.10.2. PRODUCT
PORTFOLIO
6.10.3. KEY
STRENGTHS
6.10.4. KEY
CHALLENGES
7. RESEARCH
METHODOLOGY & SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.2. SOURCES
OF DATA
7.3. RESEARCH
METHODOLOGY
TABLE
1: GLOBAL MALE INFERTILITY MARKET, BY REGIONAL
OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE
2: LIST OF COLLABORATIONS
TABLE
3: LIST OF PRODUCT LAUNCHES
TABLE
4: LIST OF MERGERS & ACQUISITIONS
TABLE
5: LIST OF BUSINESS DIVESTITURES &
EXPANSIONS
TABLE
6: GLOBAL MALE INFERTILITY MARKET, BY
TEST TYPE, 2023-2030 (IN $ MILLION)
TABLE
7: GLOBAL MALE INFERTILITY MARKET, BY
TREATMENT, 2023-2030 (IN $ MILLION)
TABLE
8: GLOBAL MALE INFERTILITY MARKET, BY
REGIONAL OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE
9: NORTH AMERICA MALE INFERTILITY
MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE
10: NORTH AMERICA MALE INFERTILITY
MARKET, BY TEST TYPE, 2023-2030 (IN $ MILLION)
TABLE
11: NORTH AMERICA MALE INFERTILITY
MARKET, BY TREATMENT, 2023-2030 (IN $ MILLION)
TABLE
12: EUROPE MALE INFERTILITY MARKET, BY
COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE
13: EUROPE MALE INFERTILITY MARKET, BY
TEST TYPE, 2023-2030 (IN $ MILLION)
TABLE
14: EUROPE MALE INFERTILITY MARKET, BY
TREATMENT, 2023-2030 (IN $ MILLION)
TABLE
15: ASIA-PACIFIC MALE INFERTILITY
MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE
16: ASIA-PACIFIC MALE INFERTILITY
MARKET, BY TEST TYPE, 2023-2030 (IN $ MILLION)
TABLE
17: ASIA-PACIFIC MALE INFERTILITY
MARKET, BY TREATMENT, 2023-2030 (IN $ MILLION)
TABLE
18: LATIN AMERICA MALE INFERTILITY
MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE
19: LATIN AMERICA MALE INFERTILITY
MARKET, BY TEST TYPE, 2023-2030 (IN $ MILLION)
TABLE
20: LATIN AMERICA MALE INFERTILITY
MARKET, BY TREATMENT, 2023-2030 (IN $ MILLION)
TABLE
21: MIDDLE EAST AND AFRICA MALE
INFERTILITY MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE
22: MIDDLE EAST AND AFRICA MALE
INFERTILITY MARKET, BY TEST TYPE, 2023-2030 (IN $ MILLION)
TABLE
23: MIDDLE EAST AND AFRICA MALE
INFERTILITY MARKET, BY TREATMENT, 2023-2030 (IN $ MILLION)
FIGURE
1: MARKET MATURITY ANALYSIS
FIGURE
2: GLOBAL MALE INFERTILITY MARKET, BY
TYPE, 2022 & 2030 (IN %)
FIGURE
3: GLOBAL MALE INFERTILITY MARKET, BY
DNA FRAGMENTATION TECHNIQUE, 2023-2030 (IN $ MILLION)
FIGURE
4: GLOBAL MALE INFERTILITY MARKET, BY
OXIDATIVE STRESS ANALYSIS, 2023-2030 (IN $ MILLION)
FIGURE
5: GLOBAL MALE INFERTILITY MARKET, BY MICROSCOPIC
EXAMINATION, 2023-2030 (IN $ MILLION)
FIGURE
6: GLOBAL MALE INFERTILITY MARKET, BY SPERM
AGGLUTINATION, 2023-2030 (IN $ MILLION)
FIGURE
7: GLOBAL MALE INFERTILITY MARKET, BY COMPUTER-ASSISTED
SEMEN ANALYSIS, 2023-2030 (IN $ MILLION)
FIGURE
8: GLOBAL MALE INFERTILITY MARKET, BY SPERM
PENETRATION ASSAY, 2023-2030 (IN $ MILLION)
FIGURE
9: GLOBAL MALE INFERTILITY MARKET, BY OTHER
TEST TYPES, 2023-2030 (IN $ MILLION)
FIGURE
10: GLOBAL MALE INFERTILITY MARKET, BY
TREATMENT, 2022 & 2030 (IN %)
FIGURE
11: GLOBAL MALE INFERTILITY MARKET, BY
ASSISTED REPRODUCTIVE TECHNOLOGY AND SURGERY, 2023-2030 (IN $ MILLION)
FIGURE
12: GLOBAL MALE INFERTILITY MARKET, BY
MEDICATIONS, 2023-2030 (IN $ MILLION)
FIGURE
13: GLOBAL MALE INFERTILITY MARKET, BY REGIONAL
OUTLOOK, 2022 & 2030 (IN %)
FIGURE
14: UNITED STATES MALE INFERTILITY
MARKET 2023-2030 (IN $ MILLION)
FIGURE
15: CANADA MALE INFERTILITY MARKET 2023-2030
(IN $ MILLION)
FIGURE
16: UNITED KINGDOM MALE INFERTILITY
MARKET 2023-2030 (IN $ MILLION)
FIGURE
17: GERMANY MALE INFERTILITY MARKET
2023-2030 (IN $ MILLION)
FIGURE
18: FRANCE MALE INFERTILITY MARKET
2023-2030 (IN $ MILLION)
FIGURE
19: ITALY MALE INFERTILITY MARKET
2023-2030 (IN $ MILLION)
FIGURE
20: SPAIN MALE INFERTILITY MARKET
2023-2030 (IN $ MILLION)
FIGURE
21: POLAND MALE INFERTILITY MARKET
2023-2030 (IN $ MILLION)
FIGURE
22: REST OF EUROPE MALE INFERTILITY
MARKET 2023-2030 (IN $ MILLION)
FIGURE
23: CHINA MALE INFERTILITY MARKET
2023-2030 (IN $ MILLION)
FIGURE
24: JAPAN MALE INFERTILITY MARKET
2023-2030 (IN $ MILLION)
FIGURE
25: INDIA MALE INFERTILITY MARKET
2023-2030 (IN $ MILLION)
FIGURE
26: SOUTH KOREA MALE INFERTILITY MARKET
2023-2030 (IN $ MILLION)
FIGURE
27: ASEAN COUNTRIES MALE INFERTILITY
MARKET 2023-2030 (IN $ MILLION)
FIGURE
28: AUSTRALIA & NEW ZEALAND MALE
INFERTILITY MARKET 2023-2030 (IN $ MILLION)
FIGURE
29: REST OF ASIA-PACIFIC MALE
INFERTILITY MARKET 2023-2030 (IN $ MILLION)
FIGURE
30: BRAZIL MALE INFERTILITY MARKET
2023-2030 (IN $ MILLION)
FIGURE
31: MEXICO MALE INFERTILITY MARKET
2023-2030 (IN $ MILLION)
FIGURE
32: REST OF LATIN AMERICA MALE
INFERTILITY MARKET 2023-2030 (IN $ MILLION)
FIGURE
33: UNITED ARAB EMIRATES MALE
INFERTILITY MARKET 2023-2030 (IN $ MILLION)
FIGURE
34: TURKEY MALE INFERTILITY MARKET
2023-2030 (IN $ MILLION)
FIGURE
35: SAUDI ARABIA MALE INFERTILITY MARKET
2023-2030 (IN $ MILLION)
FIGURE
36: SOUTH AFRICA MALE INFERTILITY MARKET
2023-2030 (IN $ MILLION)
FIGURE
37: REST OF MIDDLE EAST & AFRICA
MALE INFERTILITY MARKET 2023-2030 (IN $ MILLION)